Taysha Gene Therapies, Inc. (TSHA)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q1-2026 | 8-K (2026-05-06) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-03-19) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-04) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-12) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-15) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-02-26) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-13) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-12) · 99.1 | 8-K (2024-06-26) · 99.1 · 99.2 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-14) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-03-19) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-14) · 99.1 | ||
| 10-Q | Q2-2023 | 8-K (2023-08-14) · 99.1 · 99.2 | 8-K (2023-05-15) · 99.1 | ||
| 10-K/A | FY-2022 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | ||
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations | ||
| Consolidated Statements of Comprehensive Loss | ||
| Condensed Consolidated Statements of Stockholders' (deficit) Equity | — |
|
| Consolidated Statements of Stockholders' Equity | ||
| Condensed Consolidated Statements of Stockholders' (deficit) Equity (P) | — |
|
| Consolidated Statements of Cash Flows | ||
| Consolidated Statements of Stockholders' Equity (P) | ||
| Notes | ||
| Astellas Agreements | ||
| Balance Sheet Components | — |
|
| Commitments and Contingencies | ||
| Cybersecurity Risk Management, Strategy, and Governance Disclosure | — |
|
| Fair Value Measurements | ||
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Leases | ||
| Loan With Silicon Valley Bank | — |
|
| Net Loss Per Common Share | ||
| Organization and Description of Business Operations | ||
| Pay Vs Performance Disclosure | ||
| Research, Collaboration and License Agreements | ||
| Research, Collaboration, Grant and License Agreements | — |
|
| Retirement Plan | ||
| Segment Information | ||
| Significant Accounting Policies | — |
|
| Stock-based Compensation | ||
| Strategic Reprioritization | ||
| Subsequent Events | ||
| Summary of Significant Accounting Policies | — |
|
| Supplemental Financial Information | — |
|
| Term Loans | ||
| Warrants | ||